A Wilmore woman made quite the discovery after receiving results from a DNA kit, one that would lead to a shocking diagnosis.

One of 23andMe’s main offerings has been health information — but this has drawn criticism. Experts have long raised concerns about providing consumers with predictions of disease risk based ...

23andMe has been testing the waters for a buyer for Lemonaid Health, the virtual-care business it bought in 2021 for $400 million in cash and stock, people with knowledge of the efforts told BI.

Noura Abul-Husn, MD, PhD, Vice President of Genomic Health at 23andMe. “We’re proud to continue our commitment to developing genetic reports that impact women’s health, adding osteoporosis ...

The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts.

The Osteoporosis PRS report was developed by 23andMe scientists and clinical experts using 23andMe's database of genetic and ...

23andMe CEO Anne Wojcicki sounded optimistic ... Company's mission and believe deeply in the value of the personalized health and wellness offering that you have articulated, it is also clear ...

23andMe has also been developing a business based on partnerships with pharma companies, including GSK, to use its genetic data resources for R&D and also made a move into the online health sector ...

23andMe Holding Co. has introduced Discover23®, a new research platform allowing authorized partners to securely access a vast array of genetic data through a Trusted Research Environment (TRE ...

23andMe faced major hurdles in 2024, including a $30 million settlement related to compromised data. 23andMe is now restructuring its business operations to reduce costs and streamline operations ...